In vitro studies demonstrated that midostaurin induces G0/G1 arrest in FLT3-ITD AML cell lines and G2/M arrest in FLT3–wild-type AML cells, suggesting mutation-specific activity [49]. Here, FLT3 is linked to acute myeloid leukemia.